Your browser doesn't support javascript.
loading
Noninvasive MRI Native T1 Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of Neuroblastoma.
Zormpas-Petridis, Konstantinos; Poon, Evon; Clarke, Matthew; Jerome, Neil P; Boult, Jessica K R; Blackledge, Matthew D; Carceller, Fernando; Koers, Alexander; Barone, Giuseppe; Pearson, Andrew D J; Moreno, Lucas; Anderson, John; Sebire, Neil; McHugh, Kieran; Koh, Dow-Mu; Chesler, Louis; Yuan, Yinyin; Robinson, Simon P; Jamin, Yann.
Afiliação
  • Zormpas-Petridis K; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Trust, Sutton, Surrey, United Kingdom.
  • Poon E; Division of Clinical Studies, The Institute of Cancer Research, London and The Royal Marsden NHS Trust, Sutton, Surrey, United Kingdom.
  • Clarke M; Division of Molecular Pathology, The Institute of Cancer Research, London and The Royal Marsden NHS Trust, Sutton, Surrey, United Kingdom.
  • Jerome NP; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Trust, Sutton, Surrey, United Kingdom.
  • Boult JKR; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
  • Blackledge MD; Clinic of Radiology and Nuclear Medicine, St. Olavs Hospital, Trondheim, Norway.
  • Carceller F; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Trust, Sutton, Surrey, United Kingdom.
  • Koers A; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London and The Royal Marsden NHS Trust, Sutton, Surrey, United Kingdom.
  • Barone G; Division of Clinical Studies, The Institute of Cancer Research, London and The Royal Marsden NHS Trust, Sutton, Surrey, United Kingdom.
  • Pearson ADJ; Children & Young People's Unit, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom.
  • Moreno L; Division of Clinical Studies, The Institute of Cancer Research, London and The Royal Marsden NHS Trust, Sutton, Surrey, United Kingdom.
  • Anderson J; Department of Pediatric Oncology, Great Ormond Street Hospital for Children, London, United Kingdom.
  • Sebire N; Division of Clinical Studies, The Institute of Cancer Research, London and The Royal Marsden NHS Trust, Sutton, Surrey, United Kingdom.
  • McHugh K; Pediatric Hematology & Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Koh DM; Department of Pediatric Oncology, Great Ormond Street Hospital for Children, London, United Kingdom.
  • Chesler L; Institute of Child Health, University College London, London, United Kingdom.
  • Yuan Y; Institute of Child Health, University College London, London, United Kingdom.
  • Robinson SP; Department of Pathology, Great Ormond Street Hospital for Children, London, United Kingdom.
  • Jamin Y; Department of Radiology, Great Ormond Street Hospital for Children, London, United Kingdom.
Cancer Res ; 80(16): 3424-3435, 2020 08 15.
Article em En | MEDLINE | ID: mdl-32595135
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Benzamidas / Morfolinas / Inibidores de Proteínas Quinases / Proteína Proto-Oncogênica N-Myc / Imageamento por Ressonância Magnética Multiparamétrica / Neuroblastoma Tipo de estudo: Prognostic_studies Limite: Animals / Child / Female / Humans / Male Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Benzamidas / Morfolinas / Inibidores de Proteínas Quinases / Proteína Proto-Oncogênica N-Myc / Imageamento por Ressonância Magnética Multiparamétrica / Neuroblastoma Tipo de estudo: Prognostic_studies Limite: Animals / Child / Female / Humans / Male Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article